| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $17.4M | -8.5% | +16.6% |
| Cost of Revenue | $9.7M | -10.6% | +9.5% |
| R&D Expense | $3.8M | -15.6% | -22.9% |
| SG&A Expense | $5.0M | -14.3% | -60.9% |
| Operating Income | -$6.3M | +16.6% | +63.6% |
| Pre-tax Income | -$6.6M | +16.1% | +61.4% |
| Income Tax | $0 | — | — |
| Net Income | -$6.6M | +16.1% | +61.4% |
| EPS (Basic) | -$0.04 | +20.0% | +63.6% |
| EPS (Diluted) | -$0.04 | +20.0% | +63.6% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $42.6M | -8.9% | -48.4% |
| Accounts Receivable | $7.9M | -31.6% | -27.4% |
| Inventory | $15.1M | -16.9% | +14.0% |
| Current Assets | $79.6M | -14.8% | -46.9% |
| Total Assets | $141.6M | -8.6% | -33.7% |
| Current Liabilities | $33.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$28.1M | — | — |
| Capital Expenditures | $74K | — | — |
| Investing Cash Flow | $1.5M | — | — |
| Financing Cash Flow | -$889K | — | — |
| Free Cash Flow | -$28.2M | — | — |
| -39.8% |
| Long-term Debt | $5.0M | -6.1% | -14.6% |
| Total Liabilities | $55.7M | -11.1% | -35.3% |
| Stockholders' Equity | $85.9M | -6.9% | -32.6% |